Evidence map›Paper›PMID 38254838›Full record

ArticleCancers2024

The Cross-Scale Association between Pathomics and Radiomics Features in Immunotherapy-Treated NSCLC Patients: A Preliminary Study.

Abdou Khadir Dia, Leyla Ebrahimpour, Sevinj Yolchuyeva, Marion Tonneau, Fabien C Lamaze, Michèle Orain, Francois Coulombe, Julie Malo, Wiam Belkaid, Bertrand Routy and 3 more

Abstract read
In one paragraph

Article in Cancers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Abdou Khadir DiaDepartment of Mathematics and Computer Science, Université du Québec à Trois Rivières, Trois-Rivières, QC G8Z 4M3, Canada.ORCID 0000-0001-9820-7197
Leyla EbrahimpourQuebec Heart & Lung Institute Research Center, Québec City, QC G1V 4G5, Canada.
Sevinj YolchuyevaDepartment of Mathematics and Computer Science, Université du Québec à Trois Rivières, Trois-Rivières, QC G8Z 4M3, Canada.ORCID 0000-0001-6760-1546
Marion TonneauLille Faculty of Medicine, University of Lille, 59020 Lille, France.
Fabien C LamazeQuebec Heart & Lung Institute Research Center, Québec City, QC G1V 4G5, Canada.
Michèle OrainQuebec Heart & Lung Institute Research Center, Québec City, QC G1V 4G5, Canada.
Francois CoulombeQuebec Heart & Lung Institute Research Center, Québec City, QC G1V 4G5, Canada.
Julie MaloCentre de Recherche du Centre Hospitalier Universitaire de Montréal, Montréal, QC H2X 0A9, Canada.
Wiam BelkaidCentre de Recherche du Centre Hospitalier Universitaire de Montréal, Montréal, QC H2X 0A9, Canada.
Bertrand RoutyCentre de Recherche du Centre Hospitalier Universitaire de Montréal, Montréal, QC H2X 0A9, Canada.
Philippe JoubertQuebec Heart & Lung Institute Research Center, Québec City, QC G1V 4G5, Canada.ORCID 0000-0001-7784-6387
Philippe DesprésQuebec Heart & Lung Institute Research Center, Québec City, QC G1V 4G5, Canada.ORCID 0000-0002-4163-7353
Venkata S K ManemDepartment of Mathematics and Computer Science, Université du Québec à Trois Rivières, Trois-Rivières, QC G8Z 4M3, Canada.

Funding

CSRD VA 1
6 · The paper itself

Abstract

backgroundRecent advances in cancer biomarker development have led to a surge of distinct data modalities, such as medical imaging and histopathology. To develop predictive immunotherapy biomarkers, these modalities are leveraged independently, despite their orthogonality. This study aims to explore the cross-scale association between radiological scans and digitalized pathology images for immunotherapy-treated non-small cell lung cancer (NSCLC) patients.

methodsThis study involves 36 NSCLC patients who were treated with immunotherapy and for whom both radiology and pathology images were available. A total of 851 and 260 features were extracted from CT scans and cell density maps of histology images at different resolutions. We investigated the radiopathomics relationship and their association with clinical and biological endpoints. We used the Kolmogorov-Smirnov (KS) method to test the differences between the distributions of correlation coefficients with the two imaging modality features. Unsupervised clustering was done to identify which imaging modality captures poor and good survival patients.

resultsOur results demonstrated a significant correlation between cell density pathomics and radiomics features. Furthermore, we also found a varying distribution of correlation values between imaging-derived features and clinical endpoints. The KS test revealed that the two imaging feature distributions were different for PFS and CD8 counts, while similar for OS. In addition, clustering analysis resulted in significant differences in the two clusters generated from the radiomics and pathomics features with respect to patient survival and CD8 counts.

conclusionThe results of this study suggest a cross-scale association between CT scans and pathology H&E slides among ICI-treated patients. These relationships can be further explored to develop multimodal immunotherapy biomarkers to advance personalized lung cancer care.

Indexed as

immunotherapynon-small cell lung cancerpathomicsradiomics

Identifiers

PMID38254838
PMCPMC10813866

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.